Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions

Document Type


Publication Date


Publication Title

Catheterization and cardiovascular interventions


BACKGROUND: The clinical efficacy and safety of alcohol septal ablation (ASA) for obstructive hypertrophic cardiomyopathy (HCM) have been well-established; however, less is known about outcomes in patients undergoing preemptive ASA before transcatheter mitral valve replacement (TMVR).

AIMS: The goal of this study is to characterize the procedural characteristics and examine the clinical outcomes of ASA in both HCM and pre-TMVR.

METHODS: This retrospective study compared procedural characteristics and outcomes in patient who underwent ASA for HCM and TMVR.

RESULTS: In total, 137 patients were included, 86 in the HCM group and 51 in the TMVR group. The intraventricular septal thickness (mean 1.8 vs. 1.2 cm; p < 0.0001) and the pre-ASA LVOT gradient (73.6 vs. 33.8 mmHg; p ≤ 0.001) were higher in the HCM group vs the TMVR group. The mean volume of ethanol injected was higher (mean 2.4 vs. 1.7 cc; p < 0.0001). The average neo-left ventricular outflow tract area increased significantly after ASA in the patients undergoing TMVR (99.2 ± 83.37 mm(2) vs. 196.5 ± 114.55 mm(2); p = <0.0001). The HCM group had a greater reduction in the LVOT gradient after ASA vs the TMVR group (49.3 vs. 18 mmHg; p = 0.0040). The primary composite endpoint was higher in the TMVR group versus the HCM group (50.9% vs. 25.6%; p = 0.0404) and had a higher incidence of new permanent pacemaker (PPM) (25.5% vs. 18.6%; p = 0.3402). The TMVR group had a higher rate of all-cause mortality (9.8% vs. 1.2%; p = 0.0268).

CONCLUSIONS: Preemptive ASA before TMVR was performed in patients with higher degree of clinical comorbidities, and correspondingly is associated with worse short-term clinical outcomes in comparison to ASA for HCM patients. ASA before TMVR enabled percutaneous mitral interventions in a small but significant minority of patients that would have otherwise been excluded. The degree of LVOT and neoLVOT area increase is significant and predictable.

Medical Subject Headings

Humans; Retrospective Studies; Male; Ethanol; Cardiomyopathy, Hypertrophic; Female; Treatment Outcome; Ablation Techniques; Aged; Cardiac Catheterization; Middle Aged; Risk Factors; Heart Valve Prosthesis Implantation; Time Factors; Mitral Valve; Recovery of Function; Aged, 80 and over; Heart Septum; Mitral Valve Insufficiency

PubMed ID






First Page


Last Page